GL1X · GenesisL1 explorer

MolNFT v1 · #111810 · protein

Mif in complex with 4-[(4-oxo-2-thioxo-1,3-thiazolan-3-yl) METHYL]BENZONITRILE

4Z1T · Macrophage migration inhibitory factor: “Mif in complex with 4-[(4-oxo-2-thioxo-1,3-thiazolan-3-yl) METHYL]BENZONITRILE”. X-ray diffraction, 1 ligand (SO4), 2 pockets (best druggability 0.82). MolNFT v1 #111810 on GenesisL1: 3D…

PDB
4Z1T
Type
protein
Length
341 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Macrophage migration inhibitory factor
EC
5.3.2.1, 5.3.3.12
UniProt
P14174
Ligands
SO4
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CMacrophage migration inhibitory factor (EC 5.3.2.1, 5.3.3.12)protein11439% helix, 31% strandP14174
BMacrophage migration inhibitory factor (EC 5.3.2.1, 5.3.3.12)protein11339% helix, 31% strandP14174

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 4 copies · chains A, B, C
  • IPA · Isopropyl alcohol · additive · 2 copies · chains A, C, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15860.820.8763SO4
2610.400.8016empty

Interfaces

3 interfaces between chains.

  • B–C · 1131 Ų buried · 19 hydrogen bonds · protein-protein
  • A–C · 1130 Ų buried · 19 hydrogen bonds · protein-protein
  • A–B · 1114 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 modified (nonstandard).

Compared structures

  • 4Z1T · MIF in complex with 4-[(4-oxo-2-thioxo-1,3-thiazolan-3-yl)methyl]benzonitrile · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.